215 related articles for article (PubMed ID: 21468052)
1. Testosterone regulates cell proliferation in aggressive fibromatosis (desmoid tumour).
Hong H; Nadesan P; Poon R; Alman BA
Br J Cancer; 2011 Apr; 104(9):1452-8. PubMed ID: 21468052
[TBL] [Abstract][Full Text] [Related]
2. IFN-{beta} signaling positively regulates tumorigenesis in aggressive fibromatosis, potentially by modulating mesenchymal progenitors.
Tjandra SS; Hsu C; Goh YI; Gurung A; Poon R; Nadesan P; Alman BA
Cancer Res; 2007 Aug; 67(15):7124-31. PubMed ID: 17671179
[TBL] [Abstract][Full Text] [Related]
3. Genetic deletion of receptor for hyaluronan-mediated motility (Rhamm) attenuates the formation of aggressive fibromatosis (desmoid tumor).
Tolg C; Poon R; Fodde R; Turley EA; Alman BA
Oncogene; 2003 Oct; 22(44):6873-82. PubMed ID: 14534534
[TBL] [Abstract][Full Text] [Related]
4. The role of APC and beta-catenin in the aetiology of aggressive fibromatosis (desmoid tumors).
Lips DJ; Barker N; Clevers H; Hennipman A
Eur J Surg Oncol; 2009 Jan; 35(1):3-10. PubMed ID: 18722078
[TBL] [Abstract][Full Text] [Related]
5. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors).
Alman BA; Li C; Pajerski ME; Diaz-Cano S; Wolfe HJ
Am J Pathol; 1997 Aug; 151(2):329-34. PubMed ID: 9250146
[TBL] [Abstract][Full Text] [Related]
6. Adenomatous polyposis coli gene mutation alters proliferation through its beta-catenin-regulatory function in aggressive fibromatosis (desmoid tumor).
Li C; Bapat B; Alman BA
Am J Pathol; 1998 Sep; 153(3):709-14. PubMed ID: 9736021
[TBL] [Abstract][Full Text] [Related]
7. Targeting stem cell behavior in desmoid tumors (aggressive fibromatosis) by inhibiting hedgehog signaling.
Ghanbari-Azarnier R; Sato S; Wei Q; Al-Jazrawe M; Alman BA
Neoplasia; 2013 Jul; 15(7):712-9. PubMed ID: 23814483
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumor).
Poon R; Smits R; Li C; Jagmohan-Changur S; Kong M; Cheon S; Yu C; Fodde R; Alman BA
Oncogene; 2001 Jan; 20(4):451-60. PubMed ID: 11313976
[TBL] [Abstract][Full Text] [Related]
9. Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool.
Amary MF; Pauwels P; Meulemans E; Roemen GM; Islam L; Idowu B; Bousdras K; Diss TC; O'Donnell P; Flanagan AM
Am J Surg Pathol; 2007 Sep; 31(9):1299-309. PubMed ID: 17721184
[TBL] [Abstract][Full Text] [Related]
10. A high throughput screen identifies Nefopam as targeting cell proliferation in β-catenin driven neoplastic and reactive fibroproliferative disorders.
Poon R; Hong H; Wei X; Pan J; Alman BA
PLoS One; 2012; 7(5):e37940. PubMed ID: 22666417
[TBL] [Abstract][Full Text] [Related]
11. Analysis of APC/beta-catenin genes mutations and Wnt signalling pathway in desmoid-type fibromatosis.
Jilong Y; Jian W; Xiaoyan Z; Xiaoqiu L; Xiongzeng Z
Pathology; 2007 Jun; 39(3):319-25. PubMed ID: 17558858
[TBL] [Abstract][Full Text] [Related]
12. Molecular Pathogenesis of Sporadic Desmoid Tumours and Its Implications for Novel Therapies: A Systematised Narrative Review.
McLean TD; Duchi S; Di Bella C
Target Oncol; 2022 May; 17(3):223-252. PubMed ID: 35446005
[TBL] [Abstract][Full Text] [Related]
13. Abnormalities of the Wnt/β-catenin signalling pathway induce tumour progression in sporadic desmoid tumours: correlation between β-catenin widespread nuclear expression and VEGF overexpression.
Matono H; Tamiya S; Yokoyama R; Saito T; Iwamoto Y; Tsuneyoshi M; Oda Y
Histopathology; 2011 Sep; 59(3):368-75. PubMed ID: 22034877
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator inhibitor-1 (PAI-1) modifies the formation of aggressive fibromatosis (desmoid tumor).
Fen Li C; Kandel C; Baliko F; Nadesan P; Brünner N; Alman BA
Oncogene; 2005 Feb; 24(9):1615-24. PubMed ID: 15674349
[TBL] [Abstract][Full Text] [Related]
15. TGF-β and CTGF are Mitogenic Output Mediators of Wnt/β-Catenin Signaling in Desmoid Fibromatosis.
Varghese S; Braggio DA; Gillespie J; Toland AE; Pollock R; Mayerson J; Scharschmidt T; Iwenofu OH
Appl Immunohistochem Mol Morphol; 2017 Sep; 25(8):559-565. PubMed ID: 26894649
[TBL] [Abstract][Full Text] [Related]
16. [Abnormalities of chromosome 8, APC and beta-catenin genes in aggressive fibromatosis].
Yang JL; Wang J; Zhou XY; Zhu XZ
Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):116-20. PubMed ID: 18646694
[TBL] [Abstract][Full Text] [Related]
17. Correlation between beta-catenin widespread nuclear expression and matrix metalloproteinase-7 overexpression in sporadic desmoid tumors.
Matono H; Oda Y; Nakamori M; Tamiya S; Yamamoto H; Yokoyama R; Saito T; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2008 Dec; 39(12):1802-8. PubMed ID: 18715618
[TBL] [Abstract][Full Text] [Related]
18. Tcf-3 expression and beta-catenin mediated transcriptional activation in aggressive fibromatosis (desmoid tumour).
Tejpar S; Li C; Yu C; Poon R; Denys H; Sciot R; Van Cutsem E; Cassiman JJ; Alman BA
Br J Cancer; 2001 Jul; 85(1):98-101. PubMed ID: 11437409
[TBL] [Abstract][Full Text] [Related]
19. Analysis of β-catenin expression and exon 3 mutations in pediatric sporadic aggressive fibromatosis.
Bo N; Wang D; Wu B; Chen L; Ruixue Ma
Pediatr Dev Pathol; 2012; 15(3):173-8. PubMed ID: 21323417
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological features of 70 desmoid-type fibromatoses confirmed by β-catenin immunohistochemical staining and CTNNB1 mutation analysis.
An J; Woo HY; Lee Y; Kim HS; Jeong J; Kim SK
PLoS One; 2021; 16(4):e0250619. PubMed ID: 33914771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
